These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
354 related items for PubMed ID: 24835626
1. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells. Dandawate P, Ahmad A, Deshpande J, Swamy KV, Khan EM, Khetmalas M, Padhye S, Sarkar F. Bioorg Med Chem Lett; 2014 Jul 01; 24(13):2900-4. PubMed ID: 24835626 [Abstract] [Full Text] [Related]
2. Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells. Dandawate P, Khan E, Padhye S, Gaba H, Sinha S, Deshpande J, Venkateswara Swamy K, Khetmalas M, Ahmad A, Sarkar FH. Bioorg Med Chem Lett; 2012 May 01; 22(9):3104-8. PubMed ID: 22483392 [Abstract] [Full Text] [Related]
3. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity. Bao N, Ou J, Xu M, Guan F, Shi W, Sun J, Chen L. Eur J Med Chem; 2017 Sep 08; 137():88-95. PubMed ID: 28558333 [Abstract] [Full Text] [Related]
4. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers. Jaiswal AS, Hirsch-Weil D, Proulx ER, Hong S, Narayan S. Bioorg Med Chem Lett; 2014 Oct 15; 24(20):4850-3. PubMed ID: 25240616 [Abstract] [Full Text] [Related]
5. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents. Kaur G, Mahajan MP, Pandey MK, Singh P, Ramisetti SR, Sharma AK. Eur J Med Chem; 2014 Oct 30; 86():211-8. PubMed ID: 25164760 [Abstract] [Full Text] [Related]
6. Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents. Dweedar HE, Mahrous H, Ibrahim HS, Abdel-Aziz HA. Eur J Med Chem; 2014 May 06; 78():275-80. PubMed ID: 24686014 [Abstract] [Full Text] [Related]
7. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. J Cell Biochem; 2008 Dec 15; 105(6):1461-71. PubMed ID: 18980240 [Abstract] [Full Text] [Related]
8. Structure activity relationship of plumbagin in BRCA1 related cancer cells. K A T, T R, G R, K C S, Nair RS, G S, Banerji A, Somasundaram V, Srinivas P. Mol Carcinog; 2013 May 15; 52(5):392-403. PubMed ID: 22290577 [Abstract] [Full Text] [Related]
9. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones. Mallavadhani UV, Prasad CV, Shrivastava S, Naidu VG. Eur J Med Chem; 2014 Aug 18; 83():84-91. PubMed ID: 24953027 [Abstract] [Full Text] [Related]
10. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents. Wang R, Zhang X, Song H, Zhou S, Li S. Bioorg Med Chem Lett; 2014 Sep 01; 24(17):4304-7. PubMed ID: 25127868 [Abstract] [Full Text] [Related]
13. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia. Salum LB, Mascarello A, Canevarolo RR, Altei WF, Laranjeira AB, Neuenfeldt PD, Stumpf TR, Chiaradia-Delatorre LD, Vollmer LL, Daghestani HN, de Souza Melo CP, Silveira AB, Leal PC, Frederico MJ, do Nascimento LF, Santos AR, Andricopulo AD, Day BW, Yunes RA, Vogt A, Yunes JA, Nunes RJ. Eur J Med Chem; 2015 Sep 01; 96():504-18. PubMed ID: 25951294 [Abstract] [Full Text] [Related]
14. Molecular trail for the anticancer behavior of a novel copper carbohydrazone complex in BRCA1 mutated breast cancer. Nair RS, Potti ME, Thankappan R, Chandrika SK, Kurup MR, Srinivas P. Mol Carcinog; 2017 May 01; 56(5):1501-1514. PubMed ID: 28052399 [Abstract] [Full Text] [Related]
15. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives). Hayat F, Salahuddin A, Zargan J, Azam A. Eur J Med Chem; 2010 Dec 01; 45(12):6127-34. PubMed ID: 20961670 [Abstract] [Full Text] [Related]
16. Cytotoxicity of synthesized 1,4-naphthoquinone analogues on selected human cancer cell lines. Kishore N, Binneman B, Mahapatra A, van de Venter M, du Plessis-Stoman D, Boukes G, Houghton P, Marion Meyer JJ, Lall N. Bioorg Med Chem; 2014 Sep 01; 22(17):5013-9. PubMed ID: 25059501 [Abstract] [Full Text] [Related]
17. Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations. Bao N, Ou J, Li N, Zou P, Sun J, Chen L. Eur J Med Chem; 2018 Jun 25; 154():1-8. PubMed ID: 29772386 [Abstract] [Full Text] [Related]
18. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition. Li N, Ou J, Bao N, Chen C, Shi Z, Chen L, Sun J. Bioorg Chem; 2020 Nov 25; 104():104208. PubMed ID: 32919131 [Abstract] [Full Text] [Related]